ESR1 and cancer: The results presented in this study were performed in the human ER+-breast MCF-7, the most common cancer cell line used as experimental model of ER-positive breast cancer, because these cells closely resemble several characteristics (i.e., cellular phenotype, in vivo morphology, drug-resistance) found in patients with ER-positive breast tumors (33, 34).